abpit partners business investors news contact
News Events
news events header

Events

Webcasts

December 15, 2009 Droxidopa Study 301 and Registration Program Updatel
November 2, 2009 Q3 09 Quarterly Conference Call
October 1, 2009 Droxidopa Phase III Results
August 5, 2009 Q2 09 Quarterly Conference Call
May 6, 2009 Q1 09 Quarterly Conference Call
March 18, 2009 CH-1504 Phase II Results Conference Call
March 4, 2009 Q4 & FY 08 Quarterly Conference Call
November 21, 2008 2008 Analyst and Institutional Investor Day
November 10, 2008 Rodman & Renshaw 10th Annual Healthcare Conference
November 5, 2008 Q3 08 Quarterly Conference Call

Posters

June 11, 2009 Presentation of Data Demonstrating Efficacy of CH-4051 in Rat Collagen-Induced Arthritis Model at EULAR 2009
May 24, 2009 Presentation of Phase II Trial of Droxidopa in Intradialytic Hypotension at World Congress of Nephrology 2009
June 23, 2006 Dr. Ernest Choy reports data from Chelsea's Phase I trial of CH-1504 at EULAR
November 16, 2005 Dr. Oswaldo Castaneda presents results of pilot clinical trial of CH-1504 at ACR 2005

Abstracts

May 2006

Journal of Rheumatology publishes details of pilot clinical study; "CH-1504 appears to be clinically efficacious and may possess a superior safety and tolerance profile compared to MTX"